List of Ventolin Hfa drug patents

Ventolin Hfa is owned by Glaxosmithkline.

Ventolin Hfa contains Albuterol Sulfate.

Ventolin Hfa has a total of 4 drug patents out of which 0 drug patents have expired.

Ventolin Hfa was authorised for market use on 19 April, 2001.

Ventolin Hfa is available in aerosol, metered;inhalation dosage forms.

The generics of Ventolin Hfa are possible to be released after 26 August, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7832351 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Jun, 2023

(2 months from now)

US7832351

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Dec, 2023

(8 months from now)

US7500444 GLAXOSMITHKLINE Actuation indicator for a dispensing device
Feb, 2026

(2 years from now)

US7500444

(Pediatric)

GLAXOSMITHKLINE Actuation indicator for a dispensing device
Aug, 2026

(3 years from now)

Drugs and Companies using ALBUTEROL SULFATE ingredient

Market Authorisation Date: 19 April, 2001

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

VENTOLIN HFA family patents

3

European Union

2

Hong Kong

2

United States

2

Japan

2

Portugal

2

Denmark

2

Cyprus

2

Spain

2

United Kingdom

2

China

1

Germany

1

Brazil

1

South Africa

1

Austria

1

Canada

1

Mexico

1

Australia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in